American Journal of Respiratory and Critical Care Medicine

References
1. Bokulic RE, Hilman BC. Interstitial lung disease in children. Pediatr Clin North Am 1994;41:543567.
2. Fan LL, Langston C. Chronic interstitial lung disease in children. Pediatr Pulmonol 1993;16:184196.
3. Nicholson AG, Kim H, Corrin B, Bush A, du Bois RM, Rosenthal M, Sheppard MN. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998;33:203211.
4. Deutsch GH, Albright E, Chou PM, Cool CD, Coventry S, Davis MM, Dishop MK, Galambos C, Patterson K, Wert SE, et al. Defining the spectrum of diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease cooperative [abstract]. Mod Pathol 2005;18:304.
5. Langston C, Dishop M. Infant lung biopsy: clarifying the pathologic spectrum. Pathol Int 2004;54:S419S421.
6. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, et al.; Pathology Cooperative Group; ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:11201128.
7. Canakis A-M, Cutz E, Manson D, O’Brodovich H. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med 2002;165:15571565. (see comment).
8. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:18601863.
9. Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 2004;66:601623.
10. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:12961303. (see comment).
11. Clement A; ERS Task Force. Task Force on Chronic Interstitial Lung Disease in Immunocompetent Children. Eur Respir J 2004;24:686697.
12. Fan LL, Mullen AL, Brugman SM, Inscore SC, Parks DP, White CW. Clinical spectrum of chronic interstitial lung disease in children. J Pediatr 1992;121:867872.
13. Fan LL, Kozinetz CA, Deterding RR, Brugman SM. Evaluation of a diagnostic approach to pediatric interstitial lung disease. Pediatrics 1998;101:8285.
14. Van Hook KN, Brody AS, Deterding RR, Fan LL, Young LR. Evaluation of a definition of children's interstitial lung disease (chILD) syndrome [abstract]. Proc Am Thorac Soc 2006;3:A244.
15. Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol 2002;34:2329.
16. Fan LL, Kozinetz CA, Wojtczak HA, Chatfield BA, Cohen AH, Rothenberg SS. Diagnostic value of transbronchial, thoracoscopic, and open lung biopsy in immunocompetent children with chronic interstitial lung disease. J Pediatr 1997;131:565569.
17. Lynch DA, Hay T, Newell JD Jr, Divgi VD, Fan LL. Pediatric diffuse lung disease: diagnosis and classification using high-resolution CT. AJR Am J Roentgenol 1999;173:713718.
18. Copley SJ, Padley SP. High-resolution CT of paediatric lung disease. Eur Radiol 2001;11:25642575.
19. Vrielynck S, Mamou-Mani T, Emond S, Scheinmann P, Brunelle F, de Blic J. Diagnostic value of high-resolution CT in the evaluation of chronic infiltrative lung disease in children. AJR Am J Roentgenol 2008;191:914920.
20. Brody AS, Guillerman RP, Hay TC, Wagner BD, Young LR, Deutsch GH, Fan LL, Deterding RR. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol 2010;194:238244.
21. Popler J, Gower WA, Mogayzel PJ Jr, Nogee LM, Langston C, Wilson AC, Hay TC, Deterding RR. Familial neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol 2010;45:749755.
22. Vassal HB, Malone M, Petros AJ, Winter RM. Familial persistent pulmonary hypertension of the newborn resulting from misalignment of the pulmonary vessels (congenital alveolar capillary dysplasia). J Med Genet 1998;35:5860.
23. Boggs S, Harris MC, Hoffman DJ, Goel R, McDonald-McGinn D, Langston C, Zackai E, Ruchelli E. Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression. J Pediatr 1994;124:125128.
24. Gutierrez C, Rodriguez A, Palenzuela S, Forteza C, Rossello JL. Congenital misalignment of pulmonary veins with alveolar capillary dysplasia causing persistent neonatal pulmonary hypertension: report of two affected siblings. Pediatr Dev Pathol 2000;3:271276.
25. Fan LL, Kozinetz CA. Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 1997;156:939942.
26. Sondheimer HM, Lung MC, Brugman SM, Ikle DN, Fan LL, White CW. Pulmonary vascular disorders masquerading as interstitial lung disease. Pediatr Pulmonol 1995;20:284288.
27. Modrykamien AM, Gudavalli R, McCarthy K, Parambil J. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care 2010;55:584588.
28. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735740.
29. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009;60:569577.
30. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31:13571367.
31. Shlobin OA, Nathan SD. Pulmonary hypertension secondary to interstitial lung disease. Expert Rev Respir Med 2011;5:179189.
32. Polomis D, Runo JR, Meyer KC. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008;14:462469.
33. Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, et al.; EPOSS Group. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group. J Rheumatol 2010;37:105115.
34. Owens C. Radiology of diffuse interstitial pulmonary disease in children. Eur Radiol 2004;14:L2L12.
35. Copley SJ, Coren M, Nicholson AG, Rubens MB, Bush A, Hansell DM. Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol 2000;174:549554.
36. Donnelly LF. Use of three-dimensional reconstructed helical CT images in recognition and communication of chest wall anomalies in children. AJR Am J Roentgenol 2001;177:441445.
37. Frush DP. Pediatric CT: practical approach to diminish the radiation dose. Pediatr Radiol 2002;32:714717; discussion 751–754.
38. Long FR, Castile RG, Brody AS, Hogan MJ, Flucke RL, Filbrun DA, McCoy KS. Lungs in infants and young children: improved thin-section CT with a noninvasive controlled-ventilation technique—initial experience. Radiology 1999;212:588593.
39. Brody AS. Imaging considerations: interstitial lung disease in children. Radiol Clin North Am 2005;43:391403.
40. Lucaya J, García-Peña P, Herrera L, Enríquez G, Piqueras J. Expiratory chest CT in children. AJR Am J Roentgenol 2000;174:235241.
41. Garcia-Peña P, Lucaya J. HRCT in children: technique and indications. Eur Radiol 2004;14:L13L30.
42. Mechri M, Epaud R, Emond S, Coulomb A, Jaubert F, Tarrant A, Feldmann D, Flamein F, Clement A, de Blic J, et al. Surfactant protein C gene (SFTPC) mutation–associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis. Pediatr Pulmonol 2010;45:10211029.
43. Failo R, Wielopolski PA, Tiddens HAWM, Hop WCJ, Mucelli RP, Lequin MH. Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009;61:299306.
44. Puderbach M, Eichinger M, Gahr J, Ley S, Tuengerthal S, Schmähl A, Fink C, Plathow C, Wiebel M, Müller F-M, et al. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 2007;17:716724.
45. Long FR. High-resolution CT of the lungs in infants and young children. J Thorac Imaging 2001;16:251258.
46. Lell MM, May M, Deak P, Alibek S, Kuefner M, Kuettner A, Köhler H, Achenbach S, Uder M, Radkow T. High-pitch spiral computed tomography: effect on image quality and radiation dose in pediatric chest computed tomography. Invest Radiol 2011;46:116123.
47. Mason KP, Prescilla R, Fontaine PJ, Zurakowski D. Pediatric CT sedation: comparison of dexmedetomidine and pentobarbital. AJR Am J Roentgenol 2011;196:W194W198.
48. Chun TH, Amanullah S, Karishma-Bahl D, Machan JT, Andrada ER, Lewander WJ. Comparison of methohexital and pentobarbital as sedative agents for pediatric emergency department patients for computed tomography. Pediatr Emerg Care 2009;25:648650.
49. Sargent MA, McEachern AM, Jamieson DH, Kahwaji R. Atelectasis on pediatric chest CT: comparison of sedation techniques. Pediatr Radiol 1999;29:509513.
50. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380:499505.
51. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001;176:289296.
52. Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol 2000;30:215227.
53. Feher A, Castile R, Kisling J, Angelicchio C, Filbrun D, Flucke R, Tepper R. Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes. J Appl Physiol 1996;80:20192025.
54. Lum S, Stocks J, Castile R, Davis S, Henschen M, Jones M, Morris MG, Ranganathan S, Sly PD, Tepper R. American Thoracic Society; European Respiratory Society. Raised volume forced expirations in infants: guidelines for current practice. ATS/ERS statement. Am J Respir Crit Care Med 2005;172:14631471.
55. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS. Forced expiratory flows and volumes in infants: normative data and lung growth. Am J Respir Crit Care Med 2000;161:353359.
56. Goldstein AB, Castile RG, Davis SD, Filbrun DA, Flucke RL, McCoy KS, Tepper RS. Bronchodilator responsiveness in normal infants and young children. Am J Respir Crit Care Med 2001;164:447454.
57. Kerem E, Bentur L, England S, Reisman J, O’Brodovich H, Bryan AC, Levison H. Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis. J Pediatr 1990;116:6167.
58. Young LR, Brody AS, Inge TH, Acton JD, Bokulic RE, Langston C, Deutsch GH. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest 2011;139:10601071.
59. Kerby GS, Kopecky C, Wicox SL, Wagner B, Hay T, Popler J, Accurso FJ, Deterding RR. Infant pulmonary function testing in children with neuroendocrine cell hyperplasia with and without lung biopsy. Am J Respir Crit Care Med 2009;179:A5965.
60. Kerby GS, Wilcox SL, Heltshe SL, Accurso FJ, Deterding RR. Infant pulmonary function in pediatric interstitial lung disease [abstract]. Proc Am Thorac Soc 2005;2:A474.
61. Kerby GS, Wagner BD, Wilcox SL, Kopecky C, Deterding RR. Infant pulmonary function in patients with neuroendocrine cell hyperplasia of infancy correlates with future spirometry and room air oxygen saturations [abstract]. Am J Respir Crit Care Med 2012;185:A2487.
62. Kerby GS, Wagner BD, Popler J, Hay TC, Kopecky C, Wilcox SL, Quinones RR, Giller RH, Accurso FJ, Deterding RR. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol [online ahead of print] 20 Nov 2012; DOI:10.1002/ppul.22718.
63. Wood RE. Pediatric bronchoscopy. Chest Surg Clin N Am 1996;6:237251.
64. Riedler J, Grigg J, Robertson CF. Role of bronchoalveolar lavage in children with lung disease. Eur Respir J 1995;8:17251730.
65. Barbato A, Panizzolo C, Cracco A, de Blic J, Dinwiddie R, Zach M. Interstitial lung disease in children: a multicentre survey on diagnostic approach. Eur Respir J 2000;16:509513.
66. de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, et al.; European Respiratory Society. Bronchoalveolar lavage in children: ERS Task Force on Bronchoalveolar Lavage in Children. Eur Respir J 2000;15:217231.
67. Reynolds HY. Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung 2000;178:271293.
68. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005;172:268279.
69. Deterding RR, Laguna T, Emmett R, Sontag M, Accurso F. Cytokine profiles in bronchoalveolar lavage fluid from children with interstitial lung diseases. Proc Am Thorac Soc 2006;3:A164.
70. Thouvenin G, Abou Taam R, Flamein F, Guillot L, Le Bourgeois M, Reix P, Fayon M, Counil F, Depontbriand U, Feldmann D, et al. Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010;95:449454.
71. Popler J, Wagner BD, Accurso FJ, Deterding RR. Airway cytokine profiles in children’s interstitial lung diseases. Am J Respir Crit Care Med 2010;181:A3316.
72. Deterding RR, Wagner BD, Harris JK, Popler J, Smith BC, Katilius E, Stewart A, Nikard MP, Fan LL. Novel disease pathway and SOMAmer proteomic signatures in neuroendocrine cell hyperplasia of infancy and surfactant protein C bronchoalveolar lavage fluid [abstract]. Am J Respir Crit Care Med 2013;187:A3806.
73. Rock MJ. The diagnostic utility of bronchoalveolar lavage in immunocompetent children with unexplained infiltrates on chest radiograph. Pediatrics 1995;95:373377.
74. Baker AM, Bowton DL, Haponik EF. Decision making in nosocomial pneumonia: an analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 1995;107:8595.
75. Molina-Teran A, Hilliard TN, Saglani S, Haxby E, Scallan M, Bush A, Davies JC. Safety of endobronchial biopsy in children with cystic fibrosis. Pediatr Pulmonol 2006;41:10211024.
76. Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EWFW, Bush A, Davies JC. Airway remodelling in children with cystic fibrosis. Thorax 2007;62:10741080.
77. Turner JS, Willcox PA, Hayhurst MD, Potgieter PD. Fiberoptic bronchoscopy in the intensive care unit—a prospective study of 147 procedures in 107 patients. Crit Care Med 1994;22:259264.
78. Godfrey S. Pulmonary hemorrhage/hemoptysis in children. Pediatr Pulmonol 2004;37:476484.
79. Burkhalter A, Silverman JF, Hopkins MB III, Geisinger KR. Bronchoalveolar lavage cytology in pulmonary alveolar proteinosis. Am J Clin Pathol 1996;106:504510.
80. de Blic J. Pulmonary alveolar proteinosis in children. Paediatr Respir Rev 2004;5:316322.
81. Takemura T, Fukuda Y, Harrison M, Ferrans VJ. Ultrastructural, histochemical, and freeze-fracture evaluation of multilamellated structures in human pulmonary alveolar proteinosis. Am J Anat 1987;179:258268.
82. Réfabert L, Rambaud C, Mamou-Mani T, Scheinmann P, de Blic J. CD1a-positive cells in bronchoalveolar lavage samples from children with Langerhans cell histiocytosis. J Pediatr 1996;129:913915.
83. Basset F, Soler P, Jaurand MC, Bignon J. Ultrastructural examination of broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X: preliminary report on 4 cases. Thorax 1977;32:303306.
84. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984;115:225232.
85. Tessier V, Chadelat K, Baculard A, Housset B, Clement A. BAL in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis. Chest 1996;109:14301438.
86. Uyan ZS, Karadağ B, Ersu R, Kiyan G, Kotiloğlu E, Sirvanci S, Ercan F, Dağli T, Karakoç F, Dağli E. Early pulmonary involvement in Niemann-Pick type B disease: lung lavage is not useful. Pediatr Pulmonol 2005;40:169172.
87. Fan LL, Lung MC, Wagener JS. The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates. Pediatr Pulmonol 1997;23:813. (see comment).
88. Tredano M, de Blic J, Griese M, Fournet JC, Elion J, Bahuau M. Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism. Clin Chem Lab Med 2001;39:90108.
89. Latzin P, Tredano M, Wüst Y, de Blic J, Nicolai T, Bewig B, Stanzel F, Köhler D, Bahuau M, Griese M. Anti–GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Thorax 2005;60:3944.
90. Price A, Manson D, Cutz E, Dell S. Pulmonary alveolar proteinosis associated with anti–GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Pediatr Pulmonol 2006;41:367370.
91. Martinez-Moczygemba M, Doan ML, Elidemir O, Fan LL, Cheung SW, Lei JT, Moore JP, Tavana G, Lewis LR, Zhu Y, et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J Exp Med 2008;205:27112716.
92. Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 2008;205:27032710.
93. Parto K, Kallajoki M, Aho H, Simell O. Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients. Hum Pathol 1994;25:400407.
94. Parto K, Svedström E, Majurin ML, Härkönen R, Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest 1993;104:11761182.
95. Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, et al. Patient-derived granulocyte/macrophage colony–stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 2010;182:4961.
96. Ahrens P, Noll C, Kitz R, Willigens P, Zielen S, Hofmann D. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr Pulmonol 1999;28:8388.
97. Furuya MEY, Moreno-Córdova V, Ramírez-Figueroa JL, Vargas MH, Ramón-García G, Ramírez-San Juan DH. Cutoff value of lipid-laden alveolar macrophages for diagnosing aspiration in infants and children. Pediatr Pulmonol 2007;42:452457.
98. Knauer-Fischer S, Ratjen F. Lipid-laden macrophages in bronchoalveolar lavage fluid as a marker for pulmonary aspiration. Pediatr Pulmonol 1999;27:419422.
99. Starosta V, Kitz R, Hartl D, Marcos V, Reinhardt D, Griese M. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease. Chest 2007;132:15571564.
100. Miller J, Colasurdo GN, Khan AM, Jajoo C, Patel TJ, Fan LL, Elidemir O. Immunocytochemical detection of milk proteins in tracheal aspirates of ventilated infants: a pilot study. Pediatr Pulmonol 2002;34:369374.
101. Elidemir O, Fan LL, Colasurdo GN. A novel diagnostic method for pulmonary aspiration in a murine model: immunocytochemical staining of milk proteins in alveolar macrophages. Am J Respir Crit Care Med 2000;161:622626.
102. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, et al.; American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012;185:10041014.
103. Susarla SC, Fan LL. Diffuse alveolar hemorrhage syndromes in children. Curr Opin Pediatr 2007;19:314320.
104. Nogee LM. Genetic mechanisms of surfactant deficiency. Biol Neonate 2004;85:314318.
105. Whitsett JA, Wert SE, Xu Y. Genetic disorders of surfactant homeostasis. Biol Neonate 2005;87:283287.
106. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12:253274.
107. Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA, Ou Z, Wiszniewska J, Driscoll DJ, Maisenbacher MK, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009;84:780791. [Published erratum appears in Am J Hum Genet 85:537. (Multiple author names added)].
108. Breedveld GJ, van Dongen JWF, Danesino C, Guala A, Percy AK, Dure LS, Harper P, Lazarou LP, van der Linde H, Joosse M, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 2002;11:971979.
109. Breedveld GJ, Percy AK, MacDonald ME, de Vries BBA, Yapijakis C, Dure LS, Ippel EF, Sandkuijl LA, Heutink P, Arts WFM. Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 2002;59:579584.
110. Carré A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, Broutin-L’Hermite I, Barat P, Goizet C, Lacombe D, Moutard M-L, et al. Five new TTF1/NKX2.1 mutations in brain–lung–thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet 2009;18:22662276.
111. Devriendt K, Vanhole C, Matthijs G, de Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:13171318.
112. Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 2000;137:272276.
113. Krude H, Schütz B, Biebermann H, von Moers A, Schnabel D, Neitzel H, Tönnies H, Weise D, Lafferty A, Schwarz S, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475480.
114. Pohlenz J, Dumitrescu A, Zundel D, Martiné U, Schönberger W, Koo E, Weiss RE, Cohen RN, Kimura S, Refetoff S. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109:469473.
115. Willemsen MAAP, Breedveld GJ, Wouda S, Otten BJ, Yntema JL, Lammens M, de Vries BBA. Brain–thyroid–lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr 2005;164:2830.
116. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir G. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thorac Surg 1998;65:198202.
117. Jaklitsch MT, Linden BC, Braunlin EA, Bolman RM III, Foker JE. Open-lung biopsy guides therapy in children. Ann Thorac Surg 2001;71:17791785. (see comment).
118. Early GL, Williams TE, Kilman JW. Open lung biopsy: its effects on therapy in the pediatric patient. Chest 1985;87:467469.
119. Gauthier F, Montupet P, Renouard C, Valayer J. Surgical pulmonary biopsy in children [in French]. Chir Pediatr 1985;26:9294.
120. Coren ME, Nicholson AG, Goldstraw P, Rosenthal M, Bush A. Open lung biopsy for diffuse interstitial lung disease in children. Eur Respir J 1999;14:817821.
121. Stefanutti D, Morais L, Fournet JC, Jan D, Casanova JL, Scheinmann P, de Blic J. Value of open lung biopsy in immunocompromised children. J Pediatr 2000;137:165171. (see comment).
122. Steinberg R, Freud E, Ben-Ari J, Schonfeld T, Golinsky D, Mor C, Zer M. Open lung biopsy—successful diagnostic tool with therapeutic implication in the critically ill paediatric population. Acta Paediatr 1998;87:945948.
123. Gururangan S, Lawson RA, Jones PH, Stevens RF, Campbell RH. Evaluation of the usefulness of open lung biopsies. Pediatr Hematol Oncol 1992;9:107113.
124. Sebire NJ, Ramsay AD, Malone M. Histopathological features of open lung biopsies in children treated with extracorporeal membrane oxygenation (ECMO). Early Hum Dev 2005;81:455460.
125. Inwald D, Brown K, Gensini F, Malone M, Goldman A. Open lung biopsy in neonatal and paediatric patients referred for extracorporeal membrane oxygenation (ECMO). Thorax 2004;59:328333.
126. Bond SJ, Lee DJ, Stewart DL, Buchino JJ. Open lung biopsy in pediatric patients on extracorporeal membrane oxygenation. J Pediatr Surg 1996;31:13761378. (see comment).
127. Stillwell PC, Cooney DR, Telander RL, Weiland LH, O’Connell EJ. Limited thoracotomy in the pediatric patient. Mayo Clin Proc 1981;56:673677.
128. Rothenberg SS. Thoracoscopy in infants and children. Semin Pediatr Surg 1998;7:194201.
129. Visner GA, Faro A, Zander DS. Role of transbronchial biopsies in pediatric lung diseases. Chest 2004;126:273280.
130. Fontalvo LF, Amaral JG, Temple M, Chait PG, John P, Krishnamuthy G, Smith C, Connolly B. Percutaneous US-guided biopsies of peripheral pulmonary lesions in children. Pediatr Radiol 2006;36:491497.
131. Cahill AM, Baskin KM, Kaye RD, Fitz CR, Towbin RB. CT-guided percutaneous lung biopsy in children. J Vasc Interv Radiol 2004;15:955960.
132. Davies L, Dolgin S, Kattan M. Morbidity and mortality of open lung biopsy in children. Pediatrics 1997;99:660664.
133. Kornecki A, Shemie SD. Open lung biopsy in children with respiratory failure. Crit Care Med 2001;29:12471250.
134. Langston C, Patterson K, Dishop MK, Askin F, Baker P, Chou P, Cool C, Coventry S, Cutz E, Davis M, et al.; chILD Pathology Co-operative Group. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group. Pediatr Dev Pathol 2006;9:173180.
135. Rothenberg SS, Wagner JS, Chang JH, Fan LL. The safety and efficacy of thoracoscopic lung biopsy for diagnosis and treatment in infants and children. J Pediatr Surg 1996;31:100103, discussion 103–104.
136. Takamori S, Hayashi A, Matsuo T, Mitsuoka M, Tanigawa H, Fukunaga M, Miwa K, Sueyasu Y, Hotta M, Shirouzu K. Thoracoscopic lung biopsy for diffuse infiltrative lung disease. Kurume Med J 2000;47:263265.
137. Nogee LM. Genetic basis of children’s interstitial lung disease. Pediatr Allergy Immunol Pulmonol 2010;23:1524.
138. Langston C. Pediatric lung biopsy. In: Cagle P, editor. Diagnostic pulmonary pathology. New York: Marcel Dekker; 2000. pp. 1947.
139. Eulmesekian P, Cutz E, Parvez B, Bohn D, Adatia I. Alveolar capillary dysplasia: a six-year single center experience. J Perinat Med 2005;33:347352.
140. Fullmer JJ, Langston C, Dishop MK, Fan LL. Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes. J Pediatr 2005;146:376381.
141. Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA. Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 2005;40:11001105.
142. Bensard DD, McIntyre RC Jr, Waring BJ, Simon JS. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 1993;103:765770.
143. Ponsky TA, Rothenberg SS, Tsao K, Ostlie DJ, St Peter SD, Holcomb GW III. Thoracoscopy in children: is a chest tube necessary? J Laparoendosc Adv Surg Tech A 2009;19:S23S25.
144. Faro A, Hamvas A. Lung transplantation for inherited disorders of surfactant metabolism. NeoReviews 2008;9:e468e476.
145. Hamvas A, Nogee LM, Mallory GB Jr, Spray TL, Huddleston CB, August A, Dehner LP, deMello DE, Moxley M, Nelson R, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997;130:231239.
146. Palomar LM, Nogee LM, Sweet SC, Huddleston CB, Cole FS, Hamvas A. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr 2006;149:548553.
147. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573579.
148. Wegner DJ, Hertzberg T, Heins HB, Elmberger G, MacCoss MJ, Carlson CS, Nogee LM, Cole FS, Hamvas A. A major deletion in the surfactant protein-B gene causing lethal respiratory distress. Acta Paediatr 2007;96:516520.
149. Agrawal A, Hamvas A, Cole FS, Wambach JA, Wegner DJ, Coghill C, Harrison K, Nogee LM. An intronic ABCA3 mutation that is responsible for respiratory disease. Pediatr Res 2012;71:633637.
150. Brasch F, Schimanski S, Mühlfeld C, Barlage S, Langmann T, Aslanidis C, Boettcher A, Dada A, Schroten H, Mildenberger E, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006;174:571580.
151. Deterding RR, Sontag M, Kerby GS, Brody AS, Krawiec M, Nogee LM, Hamvas A. Clinical characteristics of surfactant protein (SP-C) mutations in children [abstract]. Proc Am Thorac Soc 2005;2:A474.
152. Flamein F, Riffault L, Muselet-Charlier C, Pernelle J, Feldmann D, Jonard L, Durand-Schneider A-M, Coulomb A, Maurice M, Nogee LM, et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet 2012;21:765775.
153. Garmany TH, Moxley MA, White FV, Dean M, Hull WM, Whitsett JA, Nogee LM, Hamvas A. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res 2006;59:801805.
154. Hamvas A, Nogee LM, Wegner DJ, Depass K, Christodoulou J, Bennetts B, McQuade LR, Gray PH, Deterding RR, Carroll TR, et al. Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes. J Pediatr 2009;155:854859.e1.
155. Nogee LM, Dunbar AE III, Wert S, Askin F, Hamvas A, Whitsett JA. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002;121(3, Suppl):20S21S.
156. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000;161:973981.
157. Wert SE, Deutsch GH, Hamvas A, Whitsett JA, Nogee LM. Mutations in the surfactant protein C gene (SFTPC) are associated with acute and chronic lung disease in full term infants [abstract]. Am J Respir Crit Care Med 2005;2:A23.
158. Garmany TH, Wambach JA, Heins HB, Watkins-Torry JM, Wegner DJ, Bennet K, An P, Land G, Saugstad OD, Henderson H, et al. Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res 2008;63:645649.
159. Hamvas A, Trusgnich M, Brice H, Baumgartner J, Hong Y, Nogee LM, Cole FS. Population-based screening for rare mutations: high-throughput DNA extraction and molecular amplification from Guthrie cards. Pediatr Res 2001;50:666668.
160. Tredano M, Cooper DN, Stuhrmann M, Christodoulou J, Chuzhanova NA, Roudot-Thoraval F, Boelle P-Y, Elion J, Jeanpierre M, Feingold J, et al. Origin of the prevalent SFTPB indel g.1549C > GAA (121ins2) mutation causing surfactant protein B (SP-B) deficiency. Am J Med Genet A 2006;140:6269.
161. Galambos C, Levy H, Cannon CL, Vargas SO, Reid LM, Cleveland R, Lindeman R, deMello DE, Wert SE, Whitsett JA, et al. Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome. Am J Respir Crit Care Med 2010;182:549554.
162. Kleinlein B, Griese M, Liebisch G, Krude H, Lohse P, Aslanidis C, Schmitz G, Peters J, Holzinger A. Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. Arch Dis Child Fetal Neonatal Ed 2011;96:F453F456.
163. Maquet E, Costagliola S, Parma J, Christophe-Hobertus C, Oligny LL, Fournet J-C, Robitaille Y, Vuissoz J-M, Payot A, Laberge S, et al. Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene. J Clin Endocrinol Metab 2009;94:197203.
164. Guillot L, Carré A, Szinnai G, Castanet M, Tron E, Jaubert F, Broutin I, Counil F, Feldmann D, Clement A, et al. NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “brain–lung–thyroid syndrome”. Hum Mutat 2010;31:E1146E1162.
165. Yu S, Shao L, Kilbride H, Zwick DL. Haploinsufficiencies of FOXF1 and FOXC2 genes associated with lethal alveolar capillary dysplasia and congenital heart disease. Am J Med Genet A 2010;152A:12571262.
166. Zufferey F, Martinet D, Osterheld M-C, Niel-Bütschi F, Giannoni E, Schmutz NB, Xia Z, Beckmann JS, Shaw-Smith C, Stankiewicz P, et al. 16q24.1 microdeletion in a premature newborn: usefulness of array-based comparative genomic hybridization in persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2011;12:e427e432.
167. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007;62:176179.
168. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:10261031 [see comment].
169. Brasch F, Griese M, Tredano M, Johnen G, Ochs M, Rieger C, Mulugeta S, Müller KM, Bahuau M, Beers MF. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J 2004;24:3039 [see comment].
170. Hamvas A, Nogee LM, White FV, Schuler P, Hackett BP, Huddleston CB, Mendeloff EN, Hsu F-F, Wert SE, Gonzales LW, et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol 2004;30:771776.
171. Nogee LM. Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell Mol Biol 2002;26:641644.
172. Stevens PA, Pettenazzo A, Brasch F, Mulugeta S, Baritussio A, Ochs M, Morrison L, Russo SJ, Beers MF. Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res 2005;57:8998.
173. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, Deutsch G, Nogee LM. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005;146:370375.
174. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, Sockrider MM, Fan LL. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008;63:366373.
175. Guillot L, Epaud R, Thouvenin G, Jonard L, Mohsni A, Couderc R, Counil F, de Blic J, Taam RA, Le Bourgeois M, et al. New surfactant protein C gene mutations associated with diffuse lung disease. J Med Genet 2009;46:490494. [Published erratum appears in J Med Genet 47:485.]
176. McBee AD, Wegner DJ, Carlson CS, Wambach JA, Yang P, Heins HB, Saugstad OD, Trusgnich MA, Watkins-Torry J, Nogee LM, et al. Recombination as a mechanism for sporadic mutation in the surfactant protein-C gene. Pediatr Pulmonol 2008;43:443450.
177. Thomas AQ, Lane K, Phillips J III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:13221328. (see comment).
178. Griese M, Ripper J, Sibbersen A, Lohse P, Lohse P, Brasch F, Schams A, Pamir A, Schaub B, Muensterer OJ, et al. Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr 2011;11:72.
179. Suzuki T, Maranda B, Sakagami T, Catellier P, Couture CY, Carey BC, Chalk C, Trapnell BC. Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations. Eur Respir J 2011;37:201204.
180. Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, et al. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med 2010;182:12921304.
181. Tanaka T, Motoi N, Tsuchihashi Y, Tazawa R, Kaneko C, Nei T, Yamamoto T, Hayashi T, Tagawa T, Nagayasu T, et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet 2011;48:205209.
182. Doyle DA, Gonzalez I, Thomas B, Scavina M. Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. J Pediatr 2004;145:190193.
183. Popa V, Colby TV, Reich SB. Pulmonary interstitial disease in Ig deficiency. Chest 2002;122:15941603.
184. Prober CG, Whyte H, Smith CR. Open lung biopsy in immunocompromised children with pulmonary infiltrates. Am J Dis Child 1984;138:6063.
185. Deterding RR, Wagener JS. Lung biopsy in immunocompromised children: when, how, and who? J Pediatr 2000;137:147149 [see comment].
186. de Blic J, Blanche S, Danel C, Le Bourgeois M, Caniglia M, Scheinmann P. Bronchoalveolar lavage in HIV infected patients with interstitial pneumonitis. Arch Dis Child 1989;64:12461250.
187. Buckley RH. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 2004;5:S225S233.
188. Tangsinmankong N, Bahna SL, Good RA. The immunologic workup of the child suspected of immunodeficiency. Ann Allergy Asthma Immunol 2001;87:362369, quiz 370, 423.
189. Gennery AR, Cant AJ. Diagnosis of severe combined immunodeficiency. J Clin Pathol 2001;54:191195.
190. de Vries E. Immunological investigations in children with recurrent respiratory infections. Paediatr Respir Rev 2001;2:3236.
191. Graham SM. HIV and respiratory infections in children. Curr Opin Pulm Med 2003;9:215220.
192. Thomas H, Risma KA, Graham TB, Brody AS, Deutsch GH, Young LR, Joseph PM. A kindred of children with interstitial lung disease. Chest 2007;132:221230.
193. Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006;28:364369.
194. Langston C, Dishop MK. Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies. Pediatr Dev Pathol 2009;12:421437.
195. Deterding RR, Young LR, Dishop M, Fan LL, Dell SD, Sweet SC, Hagood J, Redding G, Castile R, Kurland G, et al. Diffuse lung disease in older children—report of the child network review. Am J Respir Crit Care Med 2007;175:A148.
196. Travis WD, King TE Jr, Bateman ED, Lynch DA. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277304.
197. Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol 2005;40:157165.
198. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173:475482.
199. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 2007;119:S166S174.
200. Ward LM. Osteoporosis due to glucocorticoid use in children with chronic illness. Horm Res 2005;64:209221.
201. Easterbrook M. Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 1999;39:4957.
202. Chang WH, Katz BJ, Warner JEA, Vitale AT, Creel D, Digre KB. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Retina 2008;28:14781486.
203. Radley-Smith R, Aurora P. Transplantation as a treatment for end-stage pulmonary hypertension in childhood. Paediatr Respir Rev 2006;7:117122.
204. Webber SA, McCurry K, Zeevi A. Heart and lung transplantation in children. Lancet 2006;368:5369.
205. Mallory GB, Spray TL. Paediatric lung transplantation. Eur Respir J 2004;24:839845.
206. Woo MS. An overview of paediatric lung transplantation. Paediatr Respir Rev 2004;5:249254.
207. Khan MS, Heinle JS, Samayoa AX, Adachi I, Schecter MG, Mallory GB Jr, Morales DLS. Is lung transplantation survival better in infants? Analysis of over 80 infants. J Heart Lung Transplant 2013;32:4449.
208. Moreno A, Maestre J, Balcells J, Marhuenda C, Cobos N, Roman A, Soler J, Montferrer N, Liñan S, Gartner S, et al. Lung transplantation in young infants with interstitial pneumonia. Transplant Proc 2003;35:19511953.
209. Benden C, Aurora P, Edwards LB, Kucheryavaya AY, Christie JD, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The registry of the International Society for Heart and Lung Transplantation: fourteenth pediatric lung and heart–lung transplantation report 2011. J Heart Lung Transplant 2011;30:11231132.
210. Bott L, Béghin L, Devos P, Pierrat V, Matran R, Gottrand F. Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood. Pediatr Res 2006;60:340344.
211. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624630.
212. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000;137:374380.
213. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54:140. [Published erratum appears in MMWR Morb Mortal Wkly Rep 54:750.]
214. Fenton C, Scott LJ, Plosker GL. Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Paediatr Drugs 2004;6:177197.
215. Kristensen K, Hjuler T, Ravn H, Simões EAF, Stensballe LG. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012;54:810817.
216. Bluebond-Langer M. In the shadow of illness: parents and siblings of the chronically ill child. Princeton: Princeton University Press; 1996.

Related

No related items
American Journal of Respiratory and Critical Care Medicine
188
3

Click to see any corrections or updates and to confirm this is the authentic version of record